Augmented antioxidant status in Tamoxifen treated postmenopausal women with breast cancer on co-administration with Coenzyme Q10, Niacin and Riboflavin

Author： Yuvaraj Srinivasan   Premkumar Vummidi   Vijayasarathy Kothandaraman   Gangadaran Sitthu   Sachdanandam Panchanatham  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.61, Iss.6, 2008-05, pp. : 933-941

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Malignant Endometrial Polyps in Postmenopausal Breast Cancer Tamoxifen-Treated Patients

By Cohen I.   Bernheim J.   Azaria R.   Tepper R.   Sharony R.   Beyth Y.  

Gynecologic Oncology, Vol. 75, Iss. 1, 1999-10 ,pp. : 136-141

Elsevier

Access to resources Recommend Favorite

Ovarian Volume in Postmenopausal Breast Cancer Patients Treated with Tamoxifen

By Cohen I.   Altaras M.M.   Beyth Y.   Zalel Y.   Shapira J.   Yigael D.   Tepper R.  

Gynecologic Oncology, Vol. 64, Iss. 1, 1997-01 ,pp. : 105-108

Elsevier

Access to resources Recommend Favorite

Ovarian Tumors in Postmenopausal Breast Cancer Patients Treated with Tamoxifen

By Cohen I.   Beyth Y.   Tepper R.   Shapira J.   Zalel Y.   Figer A.   Cordoba M.   Yigael D.   Altaras M.M.  

Gynecologic Oncology, Vol. 60, Iss. 1, 1996-01 ,pp. : 54-58

Academic Press

Access to resources Recommend Favorite

Treatment Options For Postmenopausal Women with Tamoxifen-Resistant Advanced Breast Cancer

By Cheung K-L.   Robertson J.F.R.  

American Journal of Cancer, Vol. 1, Iss. 4, 2002-01 ,pp. : 293-300

Adis International

Access to resources Recommend Favorite

Evidence that Tamoxifen Preserves Bone Density in Late Postmenopausal Women with Breast Cancer

By Resch Alexandra   Biber Eva   Seifert Michael   Resch Heinrich  

Acta Oncologica, Vol. 37, Iss. 7-8, 1998-12 ,pp. : 661-664

Informa Healthcare

Access to resources Recommend Favorite